$36.89
5.31% yesterday
Nasdaq, Nov 15, 10:08 pm CET
ISIN
US90184D1000
Symbol
TWST
Sector
Industry

Twist Bioscience Corp. Target price 2024 - Analyst rating & recommendation

Twist Bioscience Corp. Classifications & Recommendation:

Buy
75%
Hold
17%
Sell
8%

Twist Bioscience Corp. Price Target

Target Price $51.80
Price $36.89
Potential
Number of Estimates 10
10 Analysts have issued a price target Twist Bioscience Corp. 2025 . The average Twist Bioscience Corp. target price is $51.80. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 9 Analysts recommend Twist Bioscience Corp. to buy, 2 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Twist Bioscience Corp. stock has an average upside potential 2025 of . Most analysts recommend the Twist Bioscience Corp. stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '23 2024
Estimates
Revenue Million $ 245.11 310.91
20.41% 26.85%
EBITDA Margin -72.45% -56.82%
30.55% 21.58%
Net Margin -85.95% -69.87%
25.99% 18.71%

10 Analysts have issued a sales forecast Twist Bioscience Corp. 2024 . The average Twist Bioscience Corp. sales estimate is

$311m
Unlock
. This is
5.32% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$312m 5.62%
Unlock
, the lowest is
$310m 5.07%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $245m 20.41%
2024
$311m 26.85%
Unlock
2025
$371m 19.42%
Unlock
2026
$446m 20.22%
Unlock
2027
$541m 21.20%
Unlock
2028
$657m 21.35%
Unlock

5 Analysts have issued an Twist Bioscience Corp. EBITDA forecast 2024. The average Twist Bioscience Corp. EBITDA estimate is

$-177m
Unlock
. This is
15.31% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-149m 2.83%
Unlock
, the lowest is
$-195m 27.42%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-178m 16.38%
2024
$-177m 0.53%
Unlock
2025
$-119m 32.43%
Unlock
2026
$-82.0m 31.33%
Unlock
2027
$88.0k 100.11%
Unlock
2028
$6.2m 6,945.45%
Unlock

EBITDA Margin

2023 -72.45% 30.55%
2024
-56.82% 21.58%
Unlock
2025
-32.15% 43.42%
Unlock
2026
-18.36% 42.89%
Unlock
2027
0.02% 100.11%
Unlock
2028
0.94% 4,600.00%
Unlock

5 Twist Bioscience Corp. Analysts have issued a net profit forecast 2024. The average Twist Bioscience Corp. net profit estimate is

$-217m
Unlock
. This is
2.57% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-215m 3.41%
Unlock
, the lowest is
$-220m 1.31%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-211m 10.89%
2024
$-217m 3.11%
Unlock
2025
$-147m 32.27%
Unlock
2026
$-103m 29.89%
Unlock
2027
$-72.9m 29.36%
Unlock
2028
$-44.5m 38.95%
Unlock

Net Margin

2023 -85.95% 25.99%
2024
-69.87% 18.71%
Unlock
2025
-39.62% 43.29%
Unlock
2026
-23.11% 41.67%
Unlock
2027
-13.47% 41.71%
Unlock
2028
-6.77% 49.74%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '23 2024
Estimates
Earnings Per Share $ -3.60 -3.71
10.89% 3.06%
P/E negative
EV/Sales 6.30

5 Analysts have issued a Twist Bioscience Corp. forecast for earnings per share. The average Twist Bioscience Corp. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-3.71
Unlock
. This is
2.62% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-3.68 3.41%
Unlock
, the lowest is
$-3.76 1.31%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-3.60 10.89%
2024
$-3.71 3.06%
Unlock
2025
$-2.51 32.35%
Unlock
2026
$-1.76 29.88%
Unlock
2027
$-1.25 28.98%
Unlock
2028
$-0.76 39.20%
Unlock

P/E ratio

Current -9.67 112.06%
2024
-9.94 2.79%
Unlock
2025
-14.67 47.59%
Unlock
2026
-20.93 42.67%
Unlock
2027
-29.63 41.57%
Unlock
2028
-48.54 63.82%
Unlock

Based on analysts' sales estimates for 2024, the Twist Bioscience Corp. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 6.64 122.07%
2024
6.30 5.11%
Unlock
2025
5.28 16.26%
Unlock
2026
4.39 16.82%
Unlock
2027
3.62 17.49%
Unlock
2028
2.98 17.60%
Unlock

P/S ratio

Current 7.32 78.04%
2024
6.95 5.05%
Unlock
2025
5.82 16.26%
Unlock
2026
4.84 16.82%
Unlock
2027
3.99 17.49%
Unlock
2028
3.29 17.60%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today